Skip to main content
FDA Shortage Check

Is Tazverik (Tazemetostat Hydrobromide Tablet) being discontinued?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

DISCONTINUATION NOTICE

Tazverik: being discontinued (FDA, Oct 24)

Tablets
A generic tablet, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.
DRUG
Tazverik
FDA LISTING
FORM
tablets
STATUS
Discontinuation
FIRST POSTED
Mar 27, 2026
LAST FDA UPDATE
Mar 27, 2026
AS OF
Oct 24, 2026
SOURCE

1 discontinuation notice below, in FDA's words. A discontinuation “does not necessarily create a shortage” (FDA).

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Tazemetostat Hydrobromide Tablet. 1 presentation from 1 maker.

Check your own medication, form and strength

What to ask at the counter

  1. Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
  2. Is my strength or the maker you stock affected? FDA list, by presentation
  3. Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
  4. When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Discontinuation notices

A discontinuation “does not necessarily create a shortage” (FDA).

  • Epizyme, Inc. (An Ipsen Company) told FDA it will discontinue Tazverik (posted ).

    “Discontinuation of the manufacture of the drug product”

    FDA listing: Tazemetostat Hydrobromide Tablet

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Tazverik being discontinued?
As of Oct 24, 2026, FDA lists discontinuation notices for Tazemetostat Hydrobromide Tablet, not a shortage. A discontinuation “does not necessarily create a shortage” (FDA).
When will the Tazverik shortage end?
FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Tazverik?
No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.